Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

cord blood-derived expanded natural killer cells PNK-007

A population of allogeneic lytic natural killer (NK) cells derived from human umbilical cord blood (UCB), with potential cytotoxic activity. Hematopoietic stem cells (HSC) are isolated from human UCB; this is followed by ex vivo differentiation into mature, highly lytic, NK cells, and expansion. Upon administration, the CB-derived expanded NK cells PNK-007 may lyse cancer cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	cord blood-derived expanded NK cells PNK-007 human CB-derived natural killer cells PNK-007
Code name:	PNK 007 PNK-007

cord blood-derived expanded natural killer cells PNK-007

Search NCI's Drug Dictionary